2026 Kite-Gilead Cell Therapy Innovation Program supports Stanford investigators’ early-stage preclinical and translational research to improve cell therapy safety, efficacy, and patient outcomes.
Career Development Awards from ASGCT support early-career scientists and postdoctoral fellows with transformative gene and cell therapy pilot studies to build independent research careers.
CRI Clinic and Laboratory Integration Program supports investigator teams translating cancer immunology discoveries into immune-based approaches to prevent initial cancer development and recurrence.
Gilead Sciences' Research Scholars Program funds innovative research by emerging investigators in HIV, viral hepatitis, primary biliary cholangitis, and oncology, with a focus on diversity and scientific advancement.
The Gilead Sciences Grants Program funds nonprofit-led research, education, and community initiatives in HIV, liver disease, oncology, and hematology to advance science and medical knowledge.
Gilead Sciences' Oncology RFP Opportunities fund innovative cancer research to advance clinical decision-making and improve patient outcomes.